MedTrace Logo

Procalcitonin Guided Antibiotic Therapy

NCT04240288 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-10-21

No results posted yet for this study

Summary

The overuse of antibiotics is an enormous problem facing the healthcare system both in the United States and across the world. The investigators plan to test the hypothesis that using procalcitonin levels (blood test) to guide the length of antibiotic therapy in patients with complicated intra-abdominal infections leads to shorter antibiotic treatment courses.

Conditions

  • Intra-Abdominal Infections

Interventions

OTHER

Procalcitonin-guided antibiotic treatment

Antibiotics will be administered based on the procalcitonin lab results.

OTHER

Standard of Care Antibiotic Treatment

Antibiotics will be administered based on standard of care treatment. The treating physicians will determine the treatment course.

Sponsors & Collaborators

Principal Investigators

  • Katherine Fischkoff, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-12-31
Completion
2023-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04240288 on ClinicalTrials.gov